David Badcock, CEO of Drug Science

Professionally Cannabis and Psychedelics

English - July 02, 2020 09:22 - 32 minutes - 22.2 MB - ★★★★★ - 4 ratings
Alternative Health Health & Fitness Medicine cannabis weed marijuana business investing pot potstocks cannabiz psychedelics psychedelic Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Dr. Raphael Mechoulam EXCLUSIVE - The Godfather of Cannabis

Next Episode: Carolina Nocetti, Founder & Medical Director, Intercan Brazil

Tune in to this week's episode of the Professionally Cannabis Podcast to hear exclusive insights today from David Badcock, CEO at Drug Science. As CEO of the charity spearheading Project Twenty21 – the initiative aiming to get cannabis medicine to 20,000 patients in the UK – David explores the UK cannabis landscape, the team behind Drug Science, and other projects around alcohol and psychedelics.

Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/